Join us this December to meet and reconnect with colleagues and gain invaluable insights to surmount the latest product liability litigation challenges facing the drug and medical device community today.
RENOWNED JURISTS
Honorable Karen K. Caldwell
Chief Judge
U.S. District Court, E.D. Kentucky
Chair
Judicial Panel on Multidistrict Litigation (JPML)
Honorable Kristine Baker
District Judge
U.S. District Court, District of Arkansas
Honorable Brian R. Martinotti
District Judge
U.S. District Court, District of New Jersey
Honorable John R. Tunheim
District Judge
U.S. District Court, District of Minnesota
Honorable Abbe F. Fletman
Judge
Philadelphia Court of Common Pleas
2023 Co-Chairs
Daniel Healey
Senior Corporate Counsel
Pfizer
Jobina Jones-McDonnell
Vice President, Assistant General Counsel – Litigation and Risk
Endo Pharmaceuticals
Sarah Padgitt
Associate General Counsel
Baxter
Meet, Learn From and Network With Key Industry Stakeholders Including:
Leah Lorber
Assistant General Counsel
GlaxoSmithKline
Marc Hennes
Head of Legal Investigations | Litigation
Novartis
Jean Patterson
Assistant General Counsel
Beckton Dickinson
Bill Childs
Assistant General Counsel, Litigation
3M
Larissa A. Eustice
Senior Assistant General Counsel
Bayer
Kenita Barrow
Deputy General Counsel
Otsuka Pharmaceutical
Lora Spencer
Principal Global Litigation & Investigations Counsel
Medtronic
Rachel A. Farnsworth
Senior Counsel | Litigation & Government Investigations
Bristol Myers Squibb
Zane Riester
Senior Counsel
Johnson & Johnson
Mary-Alice Barrett
Associate General Counsel
Genentech
Elizabeth Mitchell
Associate General Counsel, Global Litigation
Smith & Nephew
Jennifer A. Prioleau
SVP, Chief Legal Officer
B. Braun Medical Inc
Justin Witzmann
Director, Legal Affairs, Global Litigation
Nuvasive
Ashley Garry
Senior Counsel
Viatris
WHAT’S NEW FOR 2023
TWO Days of In-Depth Break Out Sessions
20 main conference sessions providing enhanced learning opportunities to deliver critical information on the topics most pressing to you.
Marquee Focus Sessions on Artificial Intelligence
Advanced, cutting-edge discussions on the product liability risks of AIusage in drug and device development, and the opportunities and perils of AI-assisted legal representation.
Spotlight on Proposed New Rule 16.1
Seasoned MDL practitioners will shed light on how newly proposed FRCP 16.1 will transform the future of MDL case management.
MDL Case Studies – 2023 Edition
An assessment of the year’s biggest and most complex MDLs: lessons learned from Tylenol, Zantac and Exactech.
Broadening Horizons: A Global Outlook on Drug & Device Product Liability Litigation
An exploration of critical international developments impacting drug and device product liability litigation in foreign jurisdictions.
Get ready for…
400+
Attendees
20+
Revamped Panel Discussions
65+
Speakers
Including 25+ In-House Counsel from Industry Leading Companies
3
Days of Networking
ABOUT THE CONFERENCE
For 28 years, ACI’s “Drug and Med” conference has brought together hundreds of products liability defense stakeholders from industry, private practice, and government to collaborate and strategize on the current products liability landscape as well as to anticipate what is next on the horizon.
Join us this December in New York City to meet and reconnect with colleagues and acquire invaluable insights to surmount the latest product liability litigation challenges facing the drug and medical device community today.
Our esteemed 2023 faculty will provide invaluable information on the product liability risks associated with AI in drug development and medical device usage, the potential impact of new MDL case management changes under proposed FRCP 16.1, and the benefits and risks of utilizing bankruptcy as a mass tort resolution vehicle.
Through our sophisticated panels, you will also gain insights on, when and how to successfully engage the FDA in your case, working with experts after the new Rule 702 amendments and critical international developments impacting drug and device product liability litigation in foreign jurisdictions.
We look forward to seeing you in New York City for the life sciences products liability defense bar’s most valuable gathering of the year.
Testimonials
ACI’s Drug & Medical Device Conference is THE must attend premier conference for attorneys practicing in the drug and medical device space.
The ACI Drug & Medical Device Conference is a must-attend conference to stay up-to-date – and even ahead of the curve – on the most important litigation and legal topics in this space. The panels are presented by the country’s leading law firm and in-house counsel, and are timely, informative, and engaging.
WHO YOU’LL MEET
Products liability, MDL, and Mass Tort attorneys and litigators (in-house & law firm) who represent:
- Pharmaceutical Companies
- Medical Device Companies
- Biotech Companies
WHAT SETS US APART?
Exceptional In-House
Participation
Your once-a-year opportunity to brainstorm with top in-house counsel including General Counsel and Chief Litigation Officers from diverse pharmaceutical and medical device companies and members of the products liability defense bar
Strengthen Relationships & Establish New Connections
Network and brainstorm with the Who’s Who of the products liability defense bar from leading litigators in the field as well as from over 25 in-house counsel responsible for handling litigation on behalf of the country’s top life sciences companies
The Most Relevant,
Forward-thinking Content
Join in high-level sessions focused on your most pressing challenges and opportunities
Federal and State Judges and Government Enforcers
Gain a 360 degree view of products liability litigation from all the key stakeholders
